loading
前日終値:
$14.56
開ける:
$14.65
24時間の取引高:
1.47M
Relative Volume:
0.79
時価総額:
$12.31B
収益:
$3.85B
当期純損益:
$667.93M
株価収益率:
22.45
EPS:
0.657
ネットキャッシュフロー:
$142.30M
1週間 パフォーマンス:
+3.29%
1か月 パフォーマンス:
+5.81%
6か月 パフォーマンス:
+4.31%
1年 パフォーマンス:
+4.57%
1日の値動き範囲:
Value
$14.61
$14.77
1週間の範囲:
Value
$14.23
$14.77
52週間の値動き範囲:
Value
$12.26
$16.89

Dr Reddys Laboratories Ltd Adr Stock (RDY) Company Profile

Name
名前
Dr Reddys Laboratories Ltd Adr
Name
セクター
Healthcare (1177)
Name
電話
-
Name
住所
-
Name
職員
27,048
Name
Twitter
@drreddys
Name
次回の収益日
2025-01-23
Name
最新のSEC提出書
Name
RDY's Discussions on Twitter

RDY を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Drug Manufacturers - Specialty & Generic icon
RDY
Dr Reddys Laboratories Ltd Adr
14.75 11.88B 3.85B 667.93M 142.30M 0.657
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
11.33 49.79B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
167.14 72.11B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
RDHL
Redhill Biopharma Ltd Adr
1.76 4.24M 35.75M 11.57M -26.25M -3.8069
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.80 45.01B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
17.53 19.43B 16.54B -1.64B 749.00M -1.45

Dr Reddys Laboratories Ltd Adr Stock (RDY) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-12-19 ダウングレード Nomura Buy → Neutral
2024-01-11 ダウングレード Jefferies Buy → Underperform
2023-08-29 ダウングレード HSBC Securities Buy → Hold
2023-05-18 ダウングレード Bernstein Outperform → Mkt Perform
2023-03-17 アップグレード BofA Securities Neutral → Buy
2023-01-30 開始されました JP Morgan Underweight
2022-11-14 ダウングレード Credit Suisse Neutral → Underperform
2022-01-03 再開されました BofA Securities Neutral
2021-07-27 ダウングレード Credit Suisse Outperform → Neutral
2021-02-02 アップグレード Barclays Equal Weight → Overweight
2020-09-18 アップグレード BofA Securities Neutral → Buy
2020-09-18 アップグレード Investec Sell → Hold
2020-01-28 ダウングレード CLSA Buy → Outperform
2020-01-27 ダウングレード CLSA Buy → Outperform
2020-01-09 アップグレード Citigroup Sell → Buy
2019-11-04 ダウングレード BofA/Merrill Buy → Neutral
2019-09-04 アップグレード Credit Suisse Underperform → Outperform
2019-07-01 アップグレード Macquarie Neutral → Outperform
2019-06-20 開始されました Deutsche Bank Hold
2019-06-11 開始されました Barclays Equal Weight
2019-05-20 ダウングレード Morgan Stanley Overweight → Equal-Weight
2019-02-19 アップグレード CLSA Outperform → Buy
2019-01-17 ダウングレード Citigroup Neutral → Sell
2017-09-21 アップグレード Morgan Stanley Equal-Weight → Overweight
2017-08-31 アップグレード CLSA Underperform → Outperform
2017-07-28 ダウングレード CLSA Underperform → Sell
2016-07-27 ダウングレード HSBC Securities Hold → Reduce
2016-07-27 ダウングレード Jefferies Hold → Underperform
2016-02-10 アップグレード Credit Agricole Underperform → Buy
2015-11-10 ダウングレード Citigroup Buy → Neutral
すべてを表示

Dr Reddys Laboratories Ltd Adr (RDY) 最新ニュース

pulisher
May 27, 2025

Asian Equities Gain In US Markets' Positive Start - Finimize

May 27, 2025
pulisher
May 13, 2025

Indian ADRs Surge in US Markets as Wall Street soars after US-China trade talks - Moneycontrol

May 13, 2025
pulisher
May 10, 2025

Asian Equities Climb Despite Weekly Losses - Finimize

May 10, 2025
pulisher
May 09, 2025

Dr. Reddy’s Laboratories Grants Stock Options to Employees in May 2025 - TipRanks

May 09, 2025
pulisher
May 09, 2025

Insider’s View: Deciphering Six Flags Entertainment Corp (FUN)’s Financial Health Through Ratios - DWinneX

May 09, 2025
pulisher
May 09, 2025

Balance Sheet Breakdown: Astrazeneca plc ADR (AZN)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - DWinneX

May 09, 2025
pulisher
May 09, 2025

Ratio Examination: Dr. Reddy’s Laboratories Ltd. ADR (RDY)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX

May 09, 2025
pulisher
May 09, 2025

Metric Deep Dive: Understanding Phio Pharmaceuticals Corp (PHIO) Through its Ratios - DWinneX

May 09, 2025
pulisher
May 09, 2025

Financial Analysis: Spotify Technology S.A (SPOT)’s Ratios Unveil Key Insights - DWinneX

May 09, 2025
pulisher
May 09, 2025

5 Indian ADRs crash up to 14% amid rising India-Pakistan military conflict - Trade Brains

May 09, 2025
pulisher
May 08, 2025

Indian Markets Set for Bloody Friday as Gift Nifty Signals Sharp Gap-Down Open Amid Escalating India-Pak Tensions - outlookbusiness.com

May 08, 2025
pulisher
May 08, 2025

Indian ADRs slump as India-Pakistan conflict sees escalation - Moneycontrol

May 08, 2025
pulisher
May 08, 2025

Gift Nifty, India ADRs see sharp sell-off following escalation in India-Pakistan conflict - Moneycontrol

May 08, 2025
pulisher
May 05, 2025

Validea's Top Health Care Stocks Based On Peter Lynch5/5/2025 - Nasdaq

May 05, 2025
pulisher
Apr 25, 2025

Asian ADRs See Mixed Results Despite Weekly Gains - Finimize

Apr 25, 2025
pulisher
Apr 25, 2025

Dr. Reddy’s Laboratories Ltd. ADR (RDY) Performance and Fundamentals Dashboard tells a completely different story - Sete News

Apr 25, 2025
pulisher
Apr 24, 2025

Dr. Reddy’s Looks Well Positioned for Long-Term Growth, Aided by Acquisitions and Partnerships - Morningstar

Apr 24, 2025
pulisher
Apr 23, 2025

Investing in Dr. Reddy’s Laboratories Ltd. ADR (RDY): What You Must Know - knoxdaily.com

Apr 23, 2025
pulisher
Apr 21, 2025

Dr Reddys Share Price Highlights: Dr. Reddys Stock Price History - The Economic Times

Apr 21, 2025
pulisher
Apr 20, 2025

LLY Stock Quote Price and Forecast - CNN

Apr 20, 2025
pulisher
Apr 17, 2025

NVO Stock Quote Price and Forecast - CNN

Apr 17, 2025
pulisher
Apr 16, 2025

Zacks Industry Outlook Dr. Reddy's, Sandoz And Teva Pharmaceuticals - Barchart.com

Apr 16, 2025
pulisher
Apr 16, 2025

Asian ADRs Climb, Showcasing North And South Asia Performances - Finimize

Apr 16, 2025
pulisher
Apr 14, 2025

PDD Holdings Stock Delivers Phenomenal 5.82% Surge to $95.77 on April 14 – Bullish Momentum Lifts Chinese Tech - Hindustan Herald

Apr 14, 2025
pulisher
Apr 14, 2025

3 Generic Drug Stocks To Watch Amid Trade War Jitters & Inflation Woes - Barchart.com

Apr 14, 2025
pulisher
Apr 14, 2025

Dr Reddy’s may cut workforce by 25%, including those in Rs 1 crore bracket: Report - financialexpress.com

Apr 14, 2025
pulisher
Apr 12, 2025

Asian ADRs Shine As Zai Lab And CNFinance Lead The Gains - Finimize

Apr 12, 2025
pulisher
Apr 12, 2025

Dr. Reddy's Laboratories Limited (NYSE:RDY) Shares Acquired by Massachusetts Financial Services Co. MA - MarketBeat

Apr 12, 2025
pulisher
Apr 11, 2025

Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading - TradingView

Apr 11, 2025
pulisher
Apr 11, 2025

Mixed Performance For Asian Stocks Traded On US Markets - Finimize

Apr 11, 2025
pulisher
Apr 11, 2025

Vanguard Group Inc. Purchases 3,911,404 Shares of Dr. Reddy’s Laboratories Limited (NYSE:RDY) - Defense World

Apr 11, 2025
pulisher
Apr 10, 2025

Asian Equities Traded in the US as American Depositary Receipts Tumble in Thursday Trading - TradingView

Apr 10, 2025
pulisher
Apr 10, 2025

TCS Q4 Results Highlights: Tata Group's IT giant reports slowest revenue growth in 4 years; US tariff hurt client deals - Mint

Apr 10, 2025
pulisher
Apr 09, 2025

US Tariffs on Pharma: Dr Reddy's to Sun Pharma—can Indian drugmakers escape Trump's tariff tantrums? - Mint

Apr 09, 2025
pulisher
Apr 08, 2025

Dr Reddy's Slapped Rs 2,395 Cr Income Tax Notice, Pharma Giant Denies Allegations - Medical Dialogues

Apr 08, 2025
pulisher
Apr 07, 2025

Asian Equities Traded in the US as American Depositary Receipts Sharply Lower in Monday Trading - TradingView

Apr 07, 2025
pulisher
Apr 07, 2025

Stocks to watch, April 7: IT, pharma, metals, oil-sensitive stocks, Nykaa, Dr Reddy's, Delhivery, Trent Ltd, and more - Upstox

Apr 07, 2025
pulisher
Apr 05, 2025

Dr Reddy's gets over Rs 2,395 crore show cause notice from I-T authority - Moneycontrol

Apr 05, 2025
pulisher
Apr 04, 2025

TCS, Dr Reddy's Labs among 6 large and mid-cap stocks that hit 52-week lows on Friday - The Economic Times

Apr 04, 2025
pulisher
Apr 03, 2025

Asian Equities Traded in the US as American Depositary Receipts Fall in Thursday Trading - TradingView

Apr 03, 2025
pulisher
Apr 03, 2025

Sensex Today | Stock Market Highlights: Sensex falls 322 points, Nifty slips 82 points as IT drags - CNBC TV18

Apr 03, 2025
pulisher
Apr 02, 2025

Asian Equities Traded in the US as American Depositary Receipts Trending Lower in Wednesday Trading - TradingView

Apr 02, 2025
pulisher
Apr 02, 2025

Generics Industry: India Celebrates Pharmaceutical Tariffs Exemption but Uncertainty Remains High - Morningstar

Apr 02, 2025
pulisher
Apr 01, 2025

US Tariffs on Pharma: Zydus, Dr Reddy’s at highest risk, says Jefferies; Check impact on other Indian pharma stocks - Mint

Apr 01, 2025
pulisher
Mar 29, 2025

Dr. Reddy's Laboratories Limited (NYSE:RDY) Shares Acquired by GQG Partners LLC - MarketBeat

Mar 29, 2025
pulisher
Mar 27, 2025

American Healthcare REIT Inc (AHR) Stock: A Year of Decreases and Increases - The InvestChronicle

Mar 27, 2025

Dr Reddys Laboratories Ltd Adr (RDY) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$123.66
price up icon 0.51%
drug_manufacturers_specialty_generic HCM
$13.86
price up icon 4.76%
$8.83
price up icon 2.79%
$320.37
price up icon 1.50%
$17.53
price down icon 3.42%
大文字化:     |  ボリューム (24 時間):